Body mass index and airway hyperresponsiveness in individuals without respiratory disease

European Annals of Allergy and Clinical Immunology

Volumn 40, Issue 4, 2008, Pages 130-137

  Machado, D ^a   Tavares, B ^a   Loureiro, G ^a   Conde, B ^a   Cemlyn Jones, J ^a   Calado, G ^a   Sousa, N ^a   Chieira, C ^a   Pereira, C ^a  

^a NONE

Author keywords

Airway hyperresponsiveness; Body mass index; Lung volumes; Obesity; Pulmonary function testing

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BIOTYPE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE ORGANIZATION; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NORMAL VALUE; OBESITY; PRACTICE GUIDELINE; RESPIRATORY TRACT DISEASE; STATISTICAL SIGNIFICANCE; TREADMILL EXERCISE;

ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; EXERCISE TEST; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OBESITY; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT DISEASES; RISK FACTORS; SEX FACTORS;

EID: 59749087876     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. 1.Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897-909.
2. Jones RL, Nzekwu. The effects of Body Mass Index on Lung Volumes. Chest 2006;130:827-33.
3. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy. 2007;62:102-12.
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-9.
5. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894. WHO Consultation on obesity. Geneva (Switzerland); 2000.
6. Veale D, Rabec C, Labaan JP. Respiratory complications of obesity. Breathe 2008;4:211-23
7. Charles MA, Basdevant A, Eschwege E. Prevalence of obesity in adults in France: the situation in 2000 established from the OBEPI Study. Ann Endocrinol (Paris) 2002;63:154-8.
8. Lobstein T, Millstone E; PorGrow Research Team. Context for the PorGrow study: Europe's obesity crisis. Obes Rev 2007;8 (Suppl 2):7-16.
9. James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-52.
10. Lobstein T, Baur L, Uauy R. IASO International Obesity Task-Force. Obesity in children and young people: a crisis in public health. Obesity Reviews 2004;5 Suppl 1:4-104.
11. Masoli M, Fabian D, Holt Shaun, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004;59:469-78.
12. Douwes J, Pearce N. Asthma and the westernization "package". Int J Epidemiol 2002;31:1098-102.
13. Shore SA. Obesity and Asthma: possible mechanisms. J Allergy Clin Immunol 2008;121:1087-93.
14. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006;174:112-9.
15. Sood A. Does obesity weigh heavily on the health of the human airway? J Allergy Clin Immunol 2005;115:921-4.
16. Shore SA, Fredberg JJ. Obesity, smooth muscle, and AHR. J Allergy Clin Immunol 2005;115:925-7.
17. Shore SA. Obesity and asthma: lessons from animal models. J Appl Physiol 2007;102: 516-28.
18. Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, et al. Role of TLR2, TLR4, and MyD88 in murine ozone-induced AHR and neutrophilia. J Appl Physiol 2007;103:1189-95.
19. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008;121:326-30.
20. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006;118:389-95.
21. Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, et al. Adiponectin inhibits the production of CXC receptor chemokine ligands in macrophages and reduces T-lym-phocyte recruitment in atherogenesis. Circ Res 2008;102:218-25.
22. Alberti L, Gilardini L, Girola A, Moro M, Cavagnini F, Invitti C. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab 2007;9:344-9.
23. R. Pellegrino, G. Viegi, V. Brusasco, et. al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
24. American Thoracic Society. Lung Function Testing: Selection of Reference Values and Interpretative Strategies. Am Rev Respir Dis 1991;144:1202-18.
25. Roca J, Whipp BJ, Agusti AGN, et al. ERS Task Force on Standardization of Clinical Exercise Testing. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997;10:2662-89.
26. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Official Statement of the American Thoracic Society. Am J Respir Crit Care Med 2000;161:309-29.
27. 27.Joos GF et al. Indirect airway challenges. Eur Respir J 2003;21:1050-68.
28. Sahebjami H. Dyspnea in obese healthy men. Chest 1998;114:1373-7.
29. Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis 1983;128:501-6.
30. Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir Med 1991;85:309-11.
31. Rubinstein I, Zamel N, DuBarry L, et al. Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med 1990;112:828-32.
32. Zerah F, Harf A, Perlemuter L, et al. Effects of obesity on respiratory resistance. Chest 1993; 103:1470-6.
33. Ferretti A, Giampiccolo P, Cavalli A, et al. Expiratory flow limitation and orthopnea in massively obese subjects. Chest 2001; 119:1401-8.
34. Watson RA, Pride NB. Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol 2005; 98:512-7.
35. B Tavares, C Pereira, C Ribeiro, D Machado, G Loureiro, C Chieira. Obesity and severity of asthma. Allergy 2007; 62 (supl 83):201.
36. del Rio-Navarro BE, Cisneros-Rivero MG, Berber-Eslava A, et al. Exercise induced bronchospasm in asthmatic and non-asthmatic obese children. AUergol et Immunopathol 2000;28:5-11.
37. Johnston RA, Theman TA, Shore SA. Augmented responses to ozone in obese carboxypeptidase E-deficient mice. Am J Physiol Regul Integr Comp Physiol 2006;290:R126-33.
38. Bennett WD, Hazucha MJ, Folinsbee LJ, Bromberg PA, Kissling GE, London SJ. Acute pulmonary function response to ozone in young adults as a function of body mass index. Inhal Toxicol 2007;19:1147-54.
39. Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J. Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest 2007;132:1890-7.
40. Chinn S, Jarvis D, Burney P, European Community Respiratory Health Survey. Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax 2002;57: 1028-33.
41. Litonjua AA, Sparrow D, Celedon JC, DeMolles D, Weiss ST. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax. 2002;57:581-5.
42. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not AHR. Thorax 2001;56:4-8.
43. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004;125:2046-52.
44. Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999;159:2582-8.
45. Guerra S, Wright AL, Morgan WJ, Sherrill DL, Holberg CJ, Martinez FD. Persistence of asthma symptoms during adolescence: role of obesity and age at onset of puberty. Am J Respir Crit Care Med 2004;170:78-85.
46. Real FG, Svanes C, Omenaas ER, et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol 2008;121:72-80.